tiprankstipranks
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (PL:SVE)
:SVE
Poland Market
SVE
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
RESEARCH TOOLSreports
Want to see PL:SVE full AI Analyst Report?

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (SVE) Ratios

0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Ratios

PL:SVE's free cash flow for Q4 2025 was zł0.54. For the 2025 fiscal year, PL:SVE's free cash flow was decreased by zł and operating cash flow was zł-0.46. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.90 0.90 1.07 1.47 2.26
Quick Ratio
 0.81 0.81 0.85 0.97 1.74
Cash Ratio
 0.01 0.01 0.02 0.07 1.11
Solvency Ratio
 -0.05 -0.05 0.09 0.07 0.21
Operating Cash Flow Ratio
 0.06 0.05 0.32 -0.17 0.12
Short-Term Operating Cash Flow Coverage
 0.11 0.09 0.74 -0.68 0.43
Net Current Asset Value
zł -17.50Mzł -17.50Mzł -130.96Mzł -107.69Mzł -2.17M
Leverage Ratios
Debt-to-Assets Ratio
 0.28 0.28 0.27 0.26 0.09
Debt-to-Equity Ratio
 0.68 0.68 0.66 0.62 0.14
Debt-to-Capital Ratio
 0.40 0.40 0.40 0.38 0.13
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.32 0.34 0.05
Financial Leverage Ratio
 2.44 2.44 2.46 2.36 1.55
Debt Service Coverage Ratio
 -0.04 -0.04 0.84 1.36 1.72
Interest Coverage Ratio
 -5.02 -5.21 4.00 5.11 11.77
Debt to Market Cap
 0.35 0.30 0.24 0.22 0.03
Interest Debt Per Share
 1.17 1.22 1.18 1.02 0.24
Net Debt to EBITDA
 -11.40 -11.39 3.93 4.56 -0.78
Profitability Margins
Gross Profit Margin
52.27%30.93%61.67%60.00%56.50%
EBIT Margin
-48.97%-48.98%17.76%14.10%18.22%
EBITDA Margin
-17.33%-17.34%28.23%25.41%30.57%
Operating Profit Margin
-48.98%-48.98%17.32%14.75%19.53%
Pretax Profit Margin
-56.92%-56.92%13.44%11.21%16.57%
Net Profit Margin
-47.45%-47.45%10.52%8.12%12.07%
Continuous Operations Profit Margin
-47.45%-47.45%10.52%8.12%12.07%
Net Income Per EBT
83.36%83.36%78.30%72.43%72.86%
EBT Per EBIT
116.20%116.20%77.60%75.97%84.80%
Return on Assets (ROA)
-6.55%-6.55%2.53%1.79%3.73%
Return on Equity (ROE)
-16.19%-15.99%6.22%4.22%5.76%
Return on Capital Employed (ROCE)
-12.16%-12.16%4.86%3.68%7.10%
Return on Invested Capital (ROIC)
-6.83%-6.83%3.54%2.57%4.92%
Return on Tangible Assets
-6.64%-6.64%2.54%1.79%3.74%
Earnings Yield
-8.86%-7.53%2.37%1.59%1.55%
Efficiency Ratios
Receivables Turnover
 1.85 1.85 2.01 2.89 3.34
Payables Turnover
 9.22 13.34 1.63 8.14 8.08
Inventory Turnover
 1.63 2.36 2.83 1.51 1.77
Fixed Asset Turnover
 0.26 0.26 0.30 0.28 0.52
Asset Turnover
 0.14 0.14 0.24 0.22 0.31
Working Capital Turnover Ratio
 -11.31 -8.53 8.07 2.58 1.85
Cash Conversion Cycle
 381.33 324.57 86.20 322.61 270.10
Days of Sales Outstanding
 197.57 197.58 181.65 126.36 109.19
Days of Inventory Outstanding
 223.35 154.35 128.98 241.11 206.09
Days of Payables Outstanding
 39.59 27.36 224.43 44.86 45.18
Operating Cycle
 420.92 351.93 310.63 367.48 315.28
Cash Flow Ratios
Operating Cash Flow Per Share
 0.11 0.10 0.19 -0.08 0.05
Free Cash Flow Per Share
 -0.26 -0.29 -0.40 -1.68 -0.52
CapEx Per Share
 0.37 0.39 0.59 1.60 0.56
Free Cash Flow to Operating Cash Flow
 -2.31 -2.88 -2.05 22.07 -11.47
Dividend Paid and CapEx Coverage Ratio
 0.30 0.26 0.31 -0.05 0.08
Capital Expenditure Coverage Ratio
 0.30 0.26 0.33 -0.05 0.08
Operating Cash Flow Coverage Ratio
 0.10 0.09 0.17 -0.08 0.19
Operating Cash Flow to Sales Ratio
 0.20 0.17 0.19 -0.09 0.06
Free Cash Flow Yield
-8.69%-7.86%-8.82%-39.31%-8.63%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -11.29 -13.29 42.22 63.05 64.41
Price-to-Sales (P/S) Ratio
 5.36 6.30 4.44 5.12 7.77
Price-to-Book (P/B) Ratio
 1.80 2.12 2.62 2.66 3.71
Price-to-Free Cash Flow (P/FCF) Ratio
 -11.51 -12.73 -11.34 -2.54 -11.58
Price-to-Operating Cash Flow Ratio
 26.54 36.65 23.22 -56.13 132.85
Price-to-Earnings Growth (PEG) Ratio
 -3.27 0.04 0.68 -2.32 1.69
Price-to-Fair Value
 1.80 2.12 2.62 2.66 3.71
Enterprise Value Multiple
 -42.31 -47.75 19.66 24.70 24.65
Enterprise Value
 308.01M 347.79M 398.38M 367.88M 379.70M
EV to EBITDA
 -42.31 -47.75 19.66 24.70 24.65
EV to Sales
 7.33 8.28 5.55 6.28 7.54
EV to Free Cash Flow
 -15.75 -16.71 -14.17 -3.12 -11.23
EV to Operating Cash Flow
 36.33 48.14 29.02 -68.83 128.80
Tangible Book Value Per Share
 2.12 2.22 1.70 1.60 1.61
Shareholders’ Equity Per Share
 1.65 1.72 1.72 1.60 1.61
Tax and Other Ratios
Effective Tax Rate
 0.17 0.17 0.22 0.28 0.27
Revenue Per Share
 0.55 0.58 1.02 0.83 0.77
Net Income Per Share
 -0.26 -0.27 0.11 0.07 0.09
Tax Burden
 0.83 0.83 0.78 0.72 0.73
Interest Burden
 1.16 1.16 0.76 0.80 0.91
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.89 0.89 0.45 0.31 0.25
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -0.38 -0.36 1.82 -0.81 0.35
Currency in PLN